EU Parliament votes in favour of relaxing rules on genetic modification
Last summer, the EU Commission proposed exempting certain genome-edited plants from the scope of EU genetic engineering legislation and thus facilitating their market access. The planned relaxation only affects plants that have been developed using new genomic technologies (NGT) such as the CRISPR-Cas gene scissors and are considered equivalent to conventionally bred plants, i.e. do not contain any foreign genes. This category is called NGT-1 plants.